17
Participants
Start Date
November 8, 2018
Primary Completion Date
October 9, 2019
Study Completion Date
October 10, 2019
Microgynon
fixed sequence trial
Nintedanib
fixed sequence trial
UNIV UZ Gent, Ghent
Thoraxklinik-Heidelberg gGmbH am Universitätsklinikum Heidelberg, Heidelberg
HOP Bichat, Paris
Universitätsklinikum Erlangen, Erlangen
HOP Avicenne, Bobigny
Radboud Universitair Medisch Centrum, Nijmegen
Hospital Garcia de Orta, EPE, Almada
Hospital Fernando Fonseca, EPE, Amadora
Hospital Santa Creu i Sant Pau, Barcelona
Hospital Vall d'Hebron, Barcelona
Lead Sponsor
Boehringer Ingelheim
INDUSTRY